Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Medpace Holdings (MEDP)
NASDAQ:MEDP
Medpace Holdings (MEDP) Stock Price & Analysis
448 Followers
MEDP Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$186.73 - $419.42
Previous Close$372
Volume221.67K
Average Volume (3M)254.01K
Market Cap
$11.51B
Enterprise Value$11.67B
Total Cash (Recent Filing)$39.14M
Total Debt (Recent Filing)$194.39M
Price to Earnings (P/E)41.9
Beta1.65
Next Earnings
Apr 22, 2024EPS Estimate
$2.47Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)8.88
Shares Outstanding30,759,281
10 Day Avg. Volume195,191
30 Day Avg. Volume254,015
Standard Deviation0.12
R-Squared0.35
Alpha0.02
Financial Highlights & Ratios
Price to Book (P/B)-38.16
Price to Sales (P/S)29.22
Price to Cash Flow (P/CF)35.60
P/FCF Ratio39.70
Enterprise Value/Market CapN/A
Enterprise Value/Revenue6.98
Enterprise Value/Gross Profit26.98
Enterprise Value/Ebitda34.64
Forecast
1Y Price Target
$440.33Price Target Upside18.37% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering3
Medpace Holdings News
PremiumPre-Earnings
Is MEDP a Buy, Before Earnings?
Ownership Overview
33.71% Insiders
27.78% Mutual Funds
25.14% Other Institutional Investors
13.37% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
MEDP FAQ
What was Medpace Holdings’s price range in the past 12 months?
Medpace Holdings lowest stock price was $186.73 and its highest was $419.42 in the past 12 months.
What is Medpace Holdings’s market cap?
Currently, no data Available
When is Medpace Holdings’s upcoming earnings report date?
Medpace Holdings’s upcoming earnings report date is Apr 22, 2024 which is yesterday.
How were Medpace Holdings’s earnings last quarter?
Medpace Holdings released its earnings results on Feb 12, 2024. The company reported $2.46 earnings per share for the quarter, beating the consensus estimate of $2.221 by $0.239.
Is Medpace Holdings overvalued?
According to Wall Street analysts Medpace Holdings’s price is currently Undervalued.
Does Medpace Holdings pay dividends?
Medpace Holdings does not currently pay dividends.
What is Medpace Holdings’s EPS estimate?
Medpace Holdings’s EPS estimate is $2.47.
How many shares outstanding does Medpace Holdings have?
Medpace Holdings has 30,759,281 shares outstanding.
What happened to Medpace Holdings’s price movement after its last earnings report?
Medpace Holdings reported an EPS of $2.46 in its last earnings report, beating expectations of $2.221. Following the earnings report the stock price went up 12.304%.
Which hedge fund is a major shareholder of Medpace Holdings?
Among the largest hedge funds holding Medpace Holdings’s share is Fisher Asset Management LLC. It holds Medpace Holdings’s shares valued at 37M.
---
Medpace Holdings Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$440.33 (18.37% Upside)
$440.33 (18.37% Upside)
Blogger Sentiment
Bullish
MEDP Sentiment 80%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 36.2K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $690.2M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Positive
Last 7 Days ▲ 1.4%
Last 30 Days ▼ 0.1%
Last 30 Days ▼ 0.1%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
95.60%
12-Months-Change
Fundamentals
Return on Equity
59.79%
Trailing 12-Months
Asset Growth
22.50%
Trailing 12-Months
Company Description
Medpace Holdings
Medpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Its services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance. The company was founded by August James Troendle in July 1992 and is headquartered in Cincinnati, OH.
---
MEDP Company Deck
---
MEDP Earnings Call
Q4 2024
0:00 / 0:00
---
MEDP Revenue Breakdown
31.13% Oncology
19.98% Metabolic
10.27% Cardiology
8.66% AVAI
29.95% Other
---
MEDP Stock 12 Months Forecast
Average Price Target
$440.33
▲(18.37% Upside)
Technical Analysis
Best Analysts Covering MEDP
1 Year
1 Year Success Rate
4/8 ratings generated profit
1 Year Average Return
+19.04%
upgraded a buy rating 12 months ago
Copying Sandy Draper's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of +19.04% per trade.
---